adamantane has been researched along with Graft-Versus-Host Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bourrié, B; Bribes, E; Casellas, P; De Nys, N; Esclangon, M; Galiègue, S; Garcia, L; Lair, P; Paul, R; Thomas, C; Vernières, JC | 1 |
1 other study(ies) available for adamantane and Graft-Versus-Host Disease
Article | Year |
---|---|
SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Binding, Competitive; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Enterotoxins; Female; Graft vs Host Disease; Interleukin-10; Ligands; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Protein Subunits; Receptors, sigma; Spleen; Steroid Isomerases; Syndrome; Tumor Necrosis Factor-alpha | 2002 |